10-48171029-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_001018071.4(FRMPD2):c.3403G>A(p.Val1135Met) variant causes a missense change. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 23)
Exomes 𝑓: 0.000044 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
FRMPD2
NM_001018071.4 missense
NM_001018071.4 missense
Scores
5
9
5
Clinical Significance
Conservation
PhyloP100: 5.09
Genes affected
FRMPD2 (HGNC:28572): (FERM and PDZ domain containing 2) This gene encodes a peripheral membrane protein and is located in a region of chromosome 10q that contains a segmental duplication. This copy of the gene is full-length and is in the telomeric duplicated region. Two other more centromerically proximal copies of the gene are partial and may represent pseudogenes. This full-length gene appears to function in the establishment and maintenance of cell polarization. The protein is recruited to cell-cell junctions in an E-cadherin-dependent manner, and is selectively localized at the basolateral membrane in polarized epithelial cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FRMPD2 | NM_001018071.4 | c.3403G>A | p.Val1135Met | missense_variant | 26/29 | ENST00000374201.8 | |
FRMPD2 | NM_001318191.1 | c.3328G>A | p.Val1110Met | missense_variant | 24/27 | ||
FRMPD2 | NM_001042512.3 | c.436G>A | p.Val146Met | missense_variant | 3/6 | ||
FRMPD2 | XM_017015744.2 | c.259G>A | p.Val87Met | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FRMPD2 | ENST00000374201.8 | c.3403G>A | p.Val1135Met | missense_variant | 26/29 | 1 | NM_001018071.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 19AN: 145044Hom.: 0 Cov.: 23 FAILED QC
GnomAD3 genomes
AF:
AC:
19
AN:
145044
Hom.:
Cov.:
23
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000801 AC: 3AN: 37466Hom.: 0 AF XY: 0.0000522 AC XY: 1AN XY: 19168
GnomAD3 exomes
AF:
AC:
3
AN:
37466
Hom.:
AF XY:
AC XY:
1
AN XY:
19168
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000439 AC: 31AN: 705396Hom.: 0 Cov.: 9 AF XY: 0.0000398 AC XY: 15AN XY: 377310
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
31
AN:
705396
Hom.:
Cov.:
9
AF XY:
AC XY:
15
AN XY:
377310
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000131 AC: 19AN: 145160Hom.: 0 Cov.: 23 AF XY: 0.000114 AC XY: 8AN XY: 70186
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
19
AN:
145160
Hom.:
Cov.:
23
AF XY:
AC XY:
8
AN XY:
70186
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2024 | The c.3403G>A (p.V1135M) alteration is located in exon 26 (coding exon 26) of the FRMPD2 gene. This alteration results from a G to A substitution at nucleotide position 3403, causing the valine (V) at amino acid position 1135 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;M;.
MutationTaster
Benign
N;N;N;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;D
REVEL
Uncertain
Sift
Pathogenic
.;D;D
Sift4G
Pathogenic
.;D;D
Polyphen
1.0
.;D;D
Vest4
0.68, 0.70
MVP
0.44
MPC
3.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at